LOS ANGELES
,
Oct. 11, 2024
/PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) OM.
Class Period:
August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline:
October 28, 2024
If you wish to serve as lead plaintiff of the Outset Medical lawsuit, you can submit your contact information at www.glancylaw.com/cases/Outset-Medical-Inc-1/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors the misleading nature of Outset Medical’s business predictions and statements.
Investors may join the class action lawsuit without immediate action, retaining their rights. For further details or inquiries, please contact Charles Linehan, Esquire, of GPM, Los Angeles, California, or visit www.glancylaw.com.
This press release follows the unfolding of the Outset Medical securities fraud case, attracting attention from investors and legal entities alike.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View original content to download multimedia:
Learn More
SOURCE Glancy Prongay & Murray LLP
Market News and Data brought to you by Benzinga APIs